Skip to content

CareDx CDNA Other income, net (Note 6)

Other income, net (Note 6) at other companies

NeoGenomics logo
NeoGenomicsNEO
-$12K-118%
Personalis, Inc. logo
Personalis, Inc.PSNL
$20K+143%
Veracyte logo
VeracyteVCYT
$7.33M+62.0%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Natera, Inc. logo
Natera, Inc.NTRA
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's other income, net (note 6)?
CareDx (CDNA) reported other income, net (note 6) of -$330K in Q1 2026.
How has CareDx's other income, net (note 6) changed year-over-year?
CareDx's other income, net (note 6) decreased by 211.9% year-over-year, from $295K to -$330K.
What is the long-term trend for CareDx's other income, net (note 6)?
Over 4 years (2021 to 2025), CareDx's other income, net (note 6) has grown at a -33.2% compound annual growth rate (CAGR), from -$2.63M to $524K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.